Transdermal Delivery of Ibuprofen Utilizing a Novel Solvent-Free Pressure-sensitive Adhesive (PSA): TEPI® Technology

PURPOSE: The main objective of this present study was the investigation of potential novel transdermal patch technology (TEPI®) delivering ibuprofen as the active pharmaceutical ingredient (API) using a novel poly(ether-urethane)-silicone crosslinked pressure-sensitive adhesive (PSA) as the drug res...

Descripción completa

Detalles Bibliográficos
Autores principales: Tombs, Emma L., Nikolaou, Vasiliki, Nurumbetov, Gabit, Haddleton, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816128/
https://www.ncbi.nlm.nih.gov/pubmed/29497462
http://dx.doi.org/10.1007/s12247-017-9305-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816128/
https://www.ncbi.nlm.nih.gov/pubmed/29497462
http://dx.doi.org/10.1007/s12247-017-9305-x

Ejemplares similares